Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan M Fryer

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Cardiovascular Pharmacology|July 10, 2004
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canineRyan M Fryer, Lee C Preusser, Samuel V Calzadilla, et al.
Journal of Cardiovascular Pharmacology|February 4, 2009
ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented ratsPatricia N Banfor, Pamela A Franklin, Jason A Segreti, et al.
Journal of Cardiovascular Pharmacology|December 20, 2011
Strategic integration of in vivo cardiovascular models during lead optimization: predictive value of 4 models independent of species, route of administration, and influence of anesthesiaRyan M Fryer, Paul C Harrison, Akalushi Muthukumarana, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2007
Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcetRyan M Fryer, Jason A Segreti, Deborah L Widomski, et al.
Plos One|January 4, 2013
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in ratRyan M Fryer, Akalushi Muthukumarana, Paul C Harrison, et al.
Journal of Cardiovascular Pharmacology|July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogsRyan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 20, 2008
Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant miceM Faadiel Essop, Heidi S Camp, Cheol Soo Choi, et al.
Circulation Research|March 8, 2003
12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analysesHemal H Patel, Ryan M Fryer, Eric R Gross, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2009
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibitionPamela H Franklin, Patricia N Banfor, Paul Tapang, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2016
A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 RatCarine M Boustany-Kari, Paul C Harrison, Hongxing Chen, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|July 10, 2004
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canineRyan M Fryer, Lee C Preusser, Samuel V Calzadilla, et al.
Journal of Cardiovascular Pharmacology|February 4, 2009
ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented ratsPatricia N Banfor, Pamela A Franklin, Jason A Segreti, et al.
Journal of Cardiovascular Pharmacology|December 20, 2011
Strategic integration of in vivo cardiovascular models during lead optimization: predictive value of 4 models independent of species, route of administration, and influence of anesthesiaRyan M Fryer, Paul C Harrison, Akalushi Muthukumarana, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2007
Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcetRyan M Fryer, Jason A Segreti, Deborah L Widomski, et al.
Plos One|January 4, 2013
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in ratRyan M Fryer, Akalushi Muthukumarana, Paul C Harrison, et al.
Journal of Cardiovascular Pharmacology|July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogsRyan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 20, 2008
Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant miceM Faadiel Essop, Heidi S Camp, Cheol Soo Choi, et al.
Circulation Research|March 8, 2003
12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analysesHemal H Patel, Ryan M Fryer, Eric R Gross, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2009
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibitionPamela H Franklin, Patricia N Banfor, Paul Tapang, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2016
A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 RatCarine M Boustany-Kari, Paul C Harrison, Hongxing Chen, et al.
Pageof 5